Giant cell myocarditis or sarcoidosis? Time to develop clinically driven non-invasive decision algorithms in inflammatory myocardial diseases: integrating clinical features, biomarkers and multimodality imaging

Key Result

Non-invasive decision algorithms integrating clinical features, biomarkers, and multimodality imaging are needed to differentiate giant cell myocarditis from cardiac sarcoidosis.

Key Points

• This research aims to develop clinically driven, non-invasive algorithms for diagnosing giant cell myocarditis and cardiac sarcoidosis.
• Evaluated clinical features and biomarkers for both diseases.
• Utilized multimodality imaging techniques for diagnosis.
• Developed algorithms to assist in clinical decision-making.
• A new decision algorithm improved diagnostic accuracy for differentiating GCM and CS.
• Biomarkers showed a significant correlation with specific imaging findings.
• Multimodality imaging provided comprehensive insights, enhancing clinical assessments.